Thiazole: A versatile standalone moiety contributing to the development of various drugs and biologically active agents

MF Arshad, A Alam, AA Alshammari, MB Alhazza… - Molecules, 2022 - mdpi.com
For many decades, the thiazole moiety has been an important heterocycle in the world of
chemistry. The thiazole ring consists of sulfur and nitrogen in such a fashion that the pi (π) …

[HTML][HTML] Recent developments in adenosine receptor ligands and their potential as novel drugs

CE Müller, KA Jacobson - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
Medicinal chemical approaches have been applied to all four of the adenosine receptor
(AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each …

Thiazole: A promising heterocycle for the development of potent CNS active agents

CB Mishra, S Kumari, M Tiwari - European journal of medicinal chemistry, 2015 - Elsevier
Thiazole is a valuable scaffold in the field of medicinal chemistry and has accounted to
display a variety of biological activities. Thiazole and its derivatives have attracted …

[HTML][HTML] Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction

W Namkung, Z Yao, WE Finkbeiner… - The FASEB …, 2011 - ncbi.nlm.nih.gov
Abstract TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in
secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of∼ …

[HTML][HTML] Adenosine and its receptors as therapeutic targets: an overview

S Sachdeva, M Gupta - Saudi Pharmaceutical Journal, 2013 - Elsevier
The main goal of the authors is to present an overview of adenosine and its receptors, which
are G-protein coupled receptors. The four known adenosine receptor subtypes are …

Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: current status and perspectives

PK Deb, S Deka, P Borah, SN Abed… - Current Pharmaceutical …, 2019 - ingentaconnect.com
Adenosine is a purine nucleoside, responsible for the regulation of a wide range of
physiological and pathophysiological conditions by binding with four G-protein-coupled …

Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones

A Stößel, M Schlenk, S Hinz… - Journal of medicinal …, 2013 - ACS Publications
Blockade of A2A adenosine receptors (A2AARs) and inhibition of monoamine oxidase B
(MAO-B) in the brain are considered attractive strategies for the treatment of …

Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy

K Varani, F Vincenzi, S Merighi, S Gessi… - Protein Reviews: Volume …, 2017 - Springer
Adenosine, the purine nucleoside, mediates its effects through activation of four G-protein
coupled adenosine receptors (ARs) named as A 1, A 2A, A 2B and A 3. In particular, A 1 ARs …

Synthesis, docking and ADMET prediction of novel 5-((5-substituted-1-H-1, 2, 4-triazol-3-yl) methyl)-4, 5, 6, 7-tetrahydrothieno [3, 2-c] pyridine as antifungal agents

JN Sangshetti, FAK Khan, RS Chouthe… - Chinese Chemical …, 2014 - Elsevier
Abstract A novel series of 5-((5-substituted-1H-1, 2, 4-triazol-3-yl) methyl)-4, 5, 6, 7-
tetrahydrothieno [3, 2-c] pyridines 5 (a–i) has been synthesized from thienopyridine …

Benzothiazinones: A novel class of adenosine receptor antagonists structurally unrelated to xanthine and adenine derivatives

M Gütschow, M Schlenk, J Gäb… - Journal of Medicinal …, 2012 - ACS Publications
2-(Acyl) amino-4 H-3, 1-benzothiazin-4-ones and related thienothiazinones were identified
as structurally novel antagonists at adenosine receptors (ARs). 6-Methyl-2-benzoylamino-4 …